NewLink Genetics Corp (NASDAQ:NLNK) - Share price - Overview

Stock Report

NewLink Genetics Corp NLNK

Last Price
$4.67

Day Change
0.11|2.41%

As of 20/07/2018
16:37:18 EDT | USD
Minimum 15 Minutes Delay.

Last Close4.56
Day Range4.46 - 4.80
Mkt Cap173.60Mil
52-Wk Range3.75 - 19.30
Yield %-
ISINUS6515111077
Volume499,510
P/E-2.26
P/S4.34
P/CF-3.11

Share Price

Financials
201520162017
More ...
Income Statement
Revenue68.5035.7728.71
Operating Income-33.60-90.76-72.88
Net Income-40.38-85.16-71.95
Basic EPS-1.41-2.94-2.30
Avg. Diluted Shares Outstanding292931
Balance Sheet
Current Assets208.14167.91175.47
Non Current Assets10.406.845.23
Total Assets218.54174.75180.70
Current Liabilities14.8437.9122.03
Total Liabilities---
Total Equity195.77129.47151.56
Cash Flow
Operating Cash Flow-24.09-65.95-48.28
Capital Expenditure-4.00-2.25-0.04
Free Cash Flow-28.08-68.19-48.32

In millions, except "Basic EPS". Currency is USD.

Company Profile

NewLink Genetics Corp is a clinical stage immuno-oncology company based in US. It focuses on developing novel immunotherapeutic products for the treatment of cancer. Its portfolio contains biologic and small-molecule immuno-oncology product candidates.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

76
Key Stats
More ...
Price/Earning TTM-2.20
Price/Book1.23
Price/Sales TTM4.97
Rev Growth (3 year avg)-45.00
EPS Growth (3 year avg)-
Operating Margin % TTM-253.84
Net Margin % TTM-250.60
ROE TTM-51.21
Debt/Equity0.00
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.